Rapid and sensitive determination of posaconazole in patient plasma by capillary electrophoresis with field-amplified sample stacking

Journal of Chromatography A

Volumn 1226, Issue , 2012, Pages 48-54

  Liao, Hsiao Wei ^a   Lin, Shu Wen ^a,b   Wu, Un In ^b   Kuo, Ching Hua ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Field amplified sample stacking; Plasma; Posaconazole; SPE

Indexed keywords

ANTI-FUNGAL ACTIVITY; BACK GROUND ELECTROLYTE; BIOLOGICAL SAMPLES; CLINICAL USE; FIELD-AMPLIFIED SAMPLE STACKING; FUNGAL INFECTION; LIMIT OF DETECTION; LIPOPHILICITY; LOW TOXICITY; MATRIX EFFECTS; PEAK AREA RATIOS; POSACONAZOLE; RECOVERY RATE; RELATIVE STANDARD DEVIATIONS; RUNTIMES; SAMPLE SOLUTION; SOLID-PHASE; SPE;

CAPILLARY ELECTROPHORESIS; FORMIC ACID; METHANOL; PATIENT TREATMENT; RECOVERY;

PLASMAS;

ELECTROLYTE; FORMIC ACID; ITRACONAZOLE; METHANOL; POSACONAZOLE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CAPILLARY ELECTROPHORESIS; DRUG BLOOD LEVEL; FILTER; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIPOPHILICITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION;

ELECTROPHORESIS, CAPILLARY; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIMIT OF DETECTION; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; TRIAZOLES;

EID: 84856654155     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2011.08.012     Document Type: Article

References (33)

1. Marr K.A., Carter R.A., Crippa F., Wald A., Corey L. Clin. Infect. Dis. 2002, 34:909.
2. Pfaller M.A., Messer S., Jones R.N. Antimicrob. Agents Chemother. 1997, 41:233.
3. Munayyer H.K., Mann P.A., Chau A.S., Yarosh-Tomaine T., Greene J.R., Hare R.S., Heimark L., Palermo R.E., Loebenberg D., McNicholas P.M. Antimicrob. Agents Chemother. 2004, 48:3690.
4. Pitisuttithum P., Negroni R., Graybill J.R., Bustamante B., Pappas P., Chapman S., Hare R.S., Hardalo C.J. J. Antimicrob. Chemother. 2005, 56:745.
5. Herbrecht R. Int. J. Clin. Pract. 2004, 58:612.
6. Greenberg R.N., Mullane K., van Burik J.A.H., Raad I., Abzug M.J., Anstead G., Herbrecht R., Langston A., Marr K.A., Schiller G., Schuster M., Wingard J.R., Gonzalez C.E., Revankar S.G., Corcoran G., Kryscio R.J., Hare R. Antimicrob. Agents Chemother. 2006, 50:126.
7. van Burik J.A.H., Hare R.S., Solomon H.F., Corrado M.L., Kontoyiannis D.P. Clin. Infect. Dis. 2006, 42:E61.
8. Cornely O.A., Maertens J., Winston D.J., Perfect J., Ullmann A.J., Walsh T.J., Helfgott D., Holowiecki J., Stockelberg D., Goh Y., Petrini M., Hardalo C., Suresh R., Angulo-Gonzalez D. N. Engl. J. Med. 2007, 356:348.
9. Ullmann A.J., Lipton J.H., Vesole D.H., Chandrasekar P., Langston A., Tarantolo S.R., Greinix H., Morais de Azevedo W., Reddy V., Boparai N., Pedicone L., Patino H., Durrant S. N. Engl. J. Med. 2007, 356:335.
10. Werner Christian Neubauer M.E., König A., Hieke S., Jung M., Bertz H., Kümmerer K. Antimicrob. Agents Chemother. 2010, 54:4029.
11. Thompson G.R., Rinaldi M.G., Pennick G., Dorsey S.A., Patterson T.F., Lewis J.S. Antimicrob. Agents Chemother. 2009, 53:2223.
12. Ullmann A.J., Cornely O.A., Burchardt A., Hachem R., Kontoyiannis D.P., Topelt K., Courtney R., Wexler D., Krishna G., Martinho M., Corcoran G., Raad I. Antimicrob. Agents Chemother. 2006, 50:658.
13. FDA, Noxafil (posaconazole) Drug Labeling Information September 2010 (2010), http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022003s008,022027s001lbl.pdf.
14. Krishna G., Ma L., Vickery D., Yu X., Wu I., Power E., Beresford E., Komjathy S. Antimicrob. Agents Chemother. 2009, 53:4749.
15. Sansone-Parsons A., Krishna G., Calzetta A., Wexler D., Kantesaria B., Rosenberg M.A., Saltzman M.A. Antimicrob. Agents Chemother. 2006, 50:1881.
16. Courtney R., Wexler D., Radwanski E., Lim J., Laughlin M. Br. J. Clin. Pharmacol. 2004, 57:218.
17. Krishna G., Moton A., Ma L., Medlock M.M., McLeod J. Antimicrob. Agents Chemother. 2009, 53:958.
18. Lebeaux D., Lanternier F., Elie C., Suarez F., Buzyn A., Viard J.P., Bougnoux M.E., Lecuit M., Jullien V., Lortholary O. Antimicrob. Agents Chemother. 2009, 53:5224.
19. Hope W.W., Billaud E.M., Lestner J., Denning D.W. Curr. Opin. Infect. Dis. 2008, 21:580.
20. Smith D., Andes D. Ther. Drug Monit. 2008, 30:167.
21. Ekiert R.J., Krzek J., Talik P. Talanta 2010, 82:1090.
22. Kim H., Kumari P., Laughlin M., Hilbert M.J., Indelicato S.R., Lim J., Lin C.C., Nomeir A.A. J. Chromatogr. A 2003, 987:243.
23. Muller C., Arndt M., Queckenberg C., Cornely O.A., Theisohn M. Mycoses 2006, 49:17.
24. Chhun S., Rey E., Tran A., Lortholary O., Pons G., Jullien V. J. Chromatogr. B 2007, 852:223.
25. Neubauer W., Konig A., Bolek R., Trittler R., Engelhardt M., Jung M., Kummerer K. J. Chromatogr. B 2009, 877:2493.
26. Baietto L., D'Avolio A., Ventimiglia G., De Rosa F.G., Siccardi M., Simiele M., Sciandra M., Di Perri G. Antimicrob. Agents Chemother. 2010, 54:3408.
27. Cunliffe J.M., Noren C.F., Hayes R.N., Clement R.P., Shen J.X. J. Pharm. Biomed. Anal. 2009, 50:46.
28. Rochat B., Pascual A., Pesse B., Lamoth F., Sanglard D., Decosterd L.A., Bille J., Marchetti O. Antimicrob. Agents Chemother. 2010, 54:5074.
29. Decosterd L.A., Rochat B., Pesse B., Mercier T., Tissot F., Widmer N., Bille J., Calandra T., Zanolari B., Marchetti O. Antimicrob. Agents Chemother. 2010, 54:5303.
30. Farowski F., Cornely O.A., Vehreschild J.J., Hartmann P., Bauer T., Steinbach A., Ruping M., Muller C. Antimicrob. Agents Chemother. 2010, 54:1815.
31. Osbourn D.M., Weiss D.J., Lunte C.E. Electrophoresis 2000, 21:2768.
32. Tsai I.L., Sun S.W., Liao H.W., Lin S.C., Kuo C.H. J. Chromatogr. A 2009, 1216:8296.
33. Courtney R., Radwanski E., Lim J., Laughlin M. Antimicrob. Agents Chemother. 2004, 48:804.